ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: Primary care

Does High-Intensity Interval Training Lower Inflammatory Disease Activity?

Kurt Ullman  |  November 4, 2025

Experts discuss high-intensity interval training as an underused “disease-modifying drug” for inflammatory diseases. Learn how to safely integrate it into patient treatment plans.

Filed under:ACR ConvergenceConditionsPsoriatic ArthritisRheumatoid Arthritis Tagged with:ACR Convergence 2025ACR Convergence 2025 - PsAACR Convergence 2025 - RADisease Activity Score (DAS)ExercisefatigueFlaresHIITInflammatory Diseasephysical activity

Gout & Cardiometabolic Co-Morbidities

Jason Liebowitz, MD, FACR  |  October 28, 2025

ACR Convergence 2025 experts explore gout’s deep ties to MetS, insulin resistance and cardiovascular mortality, weighing new data on colchicine, febuxostat and SGLT2 inhibitors.

Filed under:ACR ConvergenceConditionsGout and Crystalline Arthritis Tagged with:ACR Convergence 2025AllopurinolCardiovascular diseasecardiovascular riskColchicinecomorbiditiesFebuxostatGout Resource Centerhyperuricemiametabolic syndromeSGLT2 inhibitors

The 2025 ARP President’s & Merit Awards

Patrice Fusillo  |  October 25, 2025

Meet the 2025 ARP President’s & Merit Award recipients honored for their significant contributions to rheumatology research, education & patient care.

Filed under:ACR ConvergenceAwardsCareerMeeting Reports Tagged with:ACR Convergence 2025Association of Rheumatology Professionals (ARP)

What Clinicians Should Know About Midfoot Osteoarthritis

Yvonne M. Golightly, PT, MS, PhD, Jill Halstead, BSc, MSc, PhD, MRCPod, John B. Arnold, PhD, Lara S. Chapman, MSc, BPod, Catherine J. Bowen, PhD, BPod, Marian T. Hannan, DSc, MPH, Hylton B. Menz, PhD, BPod, Kade L. Paterson, PhD, BPod, BAppSci(Hons) & Martin J. Thomas, PhD, MCSP  |  October 8, 2025

Midfoot OA experts offer an overview of a common, but under-recognized, form of OA, & discuss quality of life impacts, treatments, clinical evaluation procedures & the critical need for further research.

Filed under:ConditionsGuidanceInterprofessional PerspectiveOsteoarthritis and Bone DisordersResearch Rheum Tagged with:DisparitiesExercisefootimagingmidfoot oteoarthritisNSAIDsorthoticsPainpodiatryquality of life

New Guidance on Mental Health Screening in Pediatric Rheumatology

Ruth Jessen Hickman, MD  |  October 7, 2025

Pediatric rheumatologic diseases are characterized by high rates of anxiety & depression known to impact health-related outcomes. CARRA and the ACR developed guidance statements to assess & manage mental health concerns for youths in pediatric rheumatology practice.

Filed under:Clinical Criteria/GuidelinesConditionsGuidancePediatric Conditions Tagged with:Adolescentsanxiety disordersCARRAcognitive behavioral therapyDepressionMental Healthpatient advocacyPediatric RheumatologyPediatricsscreening

Rheumatology Influencers: Dr. Dave Has a Passion for Giving Back

Linda Childers  |  September 9, 2025

Dr. Amish Dave discusses how his volunteer, advocacy & public outreach work stem from his greater commitment to community & helping others.

Filed under:CareerLegislation & AdvocacyPractice SupportProfessional TopicsProfilesWorkforce Tagged with:AdvocacyDr. Amish J. Davefellowshiphealth disparitiesLeadershipprior authorizationpublic healthRheumatology InfluencersVolunteerworkforce shortage

3 AC&R Study Summaries: Avoidable RA Hospitalizations, Psoriasis to Psoriatic Arthritis Transition, & Neighborhood Conditions in Childhood Lupus

Arthritis Care & Research  |  September 8, 2025

New studies reveal predictors for avoidable RA hospitalizations, PsA transition in psoriasis & the impact of neighborhood on childhood lupus.

Filed under:ConditionsPsoriatic ArthritisResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:AC&RBiomarkersC-reactive proteinCardiovascular diseasechildhood-onset SLEcomorbiditiesDisparitieshospitalizedPediatric RheumatologyPsA Resource CenterPsoriasisRA Resource CenterReading RheumSLE Resource Centersocioeconomic

Sjögren’s Dry Eye Requires Collaboration Among Eye Doctors, Rheumatologists

Vanessa Caceres  |  August 26, 2025

Sjögren’s dry eye requires collaboration between rheumatologists and ophthalmologists for optimal patient management and treatment of this quality-of-life issue.

Filed under:Biologics/DMARDsConditionsDrug UpdatesResearch RheumSjögren’s Disease Tagged with:autologous serum tearsCare TeamcollaborationcyclosporineDry eyeEye diseaseHYDROXYCHLOROQUINElifitegrastocularOphthalmologistReferralsicca syndromeSjögren’s Disease supplement

What ASTP/ONC’s 2025 Regulations Mean for Rheumatologists

From the College  |  August 22, 2025

The ASTP/ONC’s recently updated United States Core Data for Interoperability Version 6 includes new data elements and applicable standards to support the provision of precision medicine and better patient care across the healthcare system.

Filed under:Information Technology Tagged with:USCDI v6

Rheumatology Influencers: Dr. Christopher Morris’ Approach to Leadership

Linda Childers  |  July 10, 2025

Dr. Christopher Morris discusses his approach to training the next generation of rheumatologists to account for disparities in access to rheumatic care& the value of multidisciplinary medical organizations.

Filed under:Profiles Tagged with:AdvocacyDr. Christopher MorrisLeadershipMentorPrivate practiceRheumatology InfluencersWorkforceworkforce shortageWorkforce Solutions Committee

  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 140
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences